Global Virus Filtration Market Analysis
According to Verified Market Intelligence, the global Virus Filtration market was valued at USD 2.27 billion in 2017 and is projected to reach USD 5.71 billion by 2025, growing at a CAGR of 12.2% from 2018 to 2025.
What is Virus Filtration?
Viruses are defined as the undesired small infectious agents or particles that need to be removed for drug sterility, especially in pharmaceuticals industry. It is a crucial procedure in the pharmaceutical industry as it ensures the purity and steady consumption of valuable products, as well as optimizing the economic process and preventing loss. Virus filtration is usually performed at the end of the purification step of any process. Virus filters used in virus filtration act as a protecting medium for bioreactors by filtering buffer solutions and media. Growing virus clearance market and demand of viral disease treatments has contributed in the growth of virus filtration market.
Global Virus Filtration Market Outlook
In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and Restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
Rapid growth in R&D sector and discoveries, increasing fund availability for biopharmaceutical sector and rising government support have been driving the global virus filtration market. On the other hand, stringent regulations for validation of filtration products might act as a restraint for the overall market.
Verified Market Intelligence narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements which interests the client. The "Global Virus Filtration Market" is mainly bifurcated into sub-segments which can provide a classified data regarding latest trends in the market. This can be of a great use in gaining knowledge about the cutting-edge technologies in the market.
Global Virus Filtration Market Competitive Landscape
The "Global Virus Filtration Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as Merck KGaA, GE Healthcare, Thermo Fisher Scientific Inc., Lonza Group Ltd., Pall Corporation, Charles River Laboratories International, Inc., Sigma-Aldrich Corporation, Sartorius AG, Asahi Kasei Medical Co., Ltd., and WuXi PharmaTech (Cayman) Inc. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above mentioned players globally.
Global Virus Filtration Market Segmentation, by Product
• Kits and Reagents
• Services
• Filtration Systems
• Others
Global Virus Filtration Market Segmentation, by Application
• Medical Devices
• Water Purification
• Air Purification
• Biologicals
o Vaccines and Therapeutics
o Blood and Blood Products
o Cellular and Gene Therapy Products
o Others
Global Virus Filtration Market Segmentation, by End user
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic Research Institutes
• Medical Device Companies
Global Virus Filtration Market Geographic Scope
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Rest of Asia Pacific
• Latin America
o Brazil
• Rest of the World
Research Methodology of Verified Market Intelligence:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team at Verified Market Intelligence.
1 INTRODUCTION OF GLOBAL VIRUS FILTRATION MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL VIRUS FILTRATION MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL VIRUS FILTRATION MARKET, BY APPLICATION
5.1 Medical Devices
5.2 Water Purification
5.3 Air Purification
5.4 Biologicals
5.4.1 Vaccines and Therapeutics
5.4.2 Blood and Blood Products
5.4.3 Cellular and Gene Therapy Products
5.4.4 Others
6 GLOBAL VIRUS FILTRATION MARKET, BY PRODUCT
6.1 Kits and Reagents
6.2 Filtration Systems
6.3 Services
6.4 Other Products
7 GLOBAL VIRUS FILTRATION MARKET, BY END USER
7.1 Pharmaceutical & Biotechnology Companies
7.2 Contract Research Organizations
7.3 Academic Research Institutes
7.4 Medical Device Companies
8 GLOBAL VIRUS FILTRATION MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World
9 GLOBAL VIRUS FILTRATION MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 Merck Kgaa
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 General Electric Company
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Thermo Fisher Scientific, Inc.
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Lonza Group Ltd.
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Sartorius AG
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Asahi Kasei Medical Co., Ltd.
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Development
10.7 Wuxi Pharmatech (Cayman) Inc.
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Development
10.8 Pall Corporation
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Charles River Laboratories International, Inc.
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 Sigma-Aldrich Corporation
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
11 Appendix
11.1 Related Reports
Price : US$ 3500 |
Date : Dec 2024 |
Category : Telecom and IT |
Pages : 131 |